Safety and effectiveness of intravitreal dexamethasone implant in patients with ocular toxocariasis
Conclusions
This was the first study to investigate use of intravitreal DEX implant in OT patients, which can efficiently reduce ocular inflammation and improve BCVA in macular uninvolved patients.
Source: British Journal of Ophthalmology - Category: Opthalmology Authors: Sun, L., Huang, L., Li, S., Lu, J., Zheng, S., Ding, X. Tags: Intraocular infection and inflammation Source Type: research
More News: Cataract Removal | Cataracts | Dexamethasone | Eye Implants | Eyes | Opthalmology | Study | UK Health | Vitamin A